Control Release of Paclitexel-Coated 316L Cardiovascular Stent In Vitro

Abstract:

Article Preview

Now the Cardio vascular restenosis in the clinic is still an unsolved question. The fact is that, if the 316L stent is without coating, it will harm the blood vessel wall and the inflammatory reaction of eye winker. This research is about the Paclitexel-drug coating stent that can be adapted to avoid restenosis. The drug control released by different methods, and also the nano-material releasing after the coating formation are investigated.

Info:

Periodical:

Key Engineering Materials (Volumes 288-289)

Edited by:

Xingdong Zhang, Junzo Tanaka, Yaoting Yu and Yasuhiko Tabata

Pages:

583-586

DOI:

10.4028/www.scientific.net/KEM.288-289.583

Citation:

H. Dong et al., "Control Release of Paclitexel-Coated 316L Cardiovascular Stent In Vitro", Key Engineering Materials, Vols. 288-289, pp. 583-586, 2005

Online since:

June 2005

Export:

Price:

$35.00

In order to see related information, you need to Login.

In order to see related information, you need to Login.